Home › Funds › PLATINUM INVESTMENT MANAGEMENT LTD › PRQR
PLATINUM INVESTMENT MANAGEMENT LTD position in PRQR
PROQR THRAPEUTICS N V · Health Care
PLATINUM INVESTMENT MANAGEMENT LTD reported holding 1,159,428 shares of PRQR (PROQR THRAPEUTICS N V) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.99% of its reported portfolio and ranking #36 among its reported holdings. PLATINUM INVESTMENT MANAGEMENT LTD has disclosed PRQR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PLATINUM INVESTMENT MANAGEMENT LTD's PRQR position evolved
PLATINUM INVESTMENT MANAGEMENT LTD first disclosed a stake in PRQR in Q4 2024 at 1,538,247 shares (US$4.1M). Across 8 filings, PLATINUM INVESTMENT MANAGEMENT LTD increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,159,428 shares valued at US$1.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.54M | $4.08M | New |
| Q1 2025 | 1.54M | $2.05M | Hold |
| Q2 2025 | 1.45M | $2.96M | Reduce |
| Q3 2025 | 1.24M | $2.63M | Reduce |
| Q4 2025 | 1.24M | $2.50M | Hold |
| Q1 2026 | 1.24M | $2.00M | Hold |
| Q2 2026 | 1.16M | $2.16M | Reduce |
| Q3 2026 | 1.16M | $1.92M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRQR and 13F data
PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 36 other funds we track also report a position in PRQR — the largest reported positions include Privium Fund Management B.V. (US$9.1M), Ikarian Capital, LLC (US$6.4M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRQR
- Privium Fund Management B.V. 5.47M sh · $9.08M · Q3 2026
- Ikarian Capital, LLC 3.43M sh · $6.37M · Q2 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 2.76M sh · $5.14M · Q2 2026
- DAFNA Capital Management LLC 1.53M sh · $2.85M · Q2 2026
- Squadron Capital Management LLC 1.51M sh · $2.81M · Q2 2026
- Kynam Capital Management, LP 1.57M sh · $2.60M · Q3 2026
- Monaco Asset Management SAM 634.92K sh · $1.05M · Q3 2026
- M28 Capital Management LP 599.79K sh · $995.66K · Q3 2026
- Lynx1 Capital Management LP 521.41K sh · $969.83K · Q2 2026
More on PLATINUM INVESTMENT MANAGEMENT LTD
FAQ
How long has PLATINUM INVESTMENT MANAGEMENT LTD held PRQR?
PLATINUM INVESTMENT MANAGEMENT LTD has disclosed PRQR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is PLATINUM INVESTMENT MANAGEMENT LTD's current position in PRQR?
As of Q3 2026, PLATINUM INVESTMENT MANAGEMENT LTD holds 1.16M shares of PRQR (PROQR THRAPEUTICS N V), valued at $1.92M, representing 0.99% of its reported portfolio and ranking #36.
Has PLATINUM INVESTMENT MANAGEMENT LTD been buying or selling PRQR?
In the latest 13F filing (Q3 2026), PLATINUM INVESTMENT MANAGEMENT LTD held unchanged its position in PRQR.
Which other funds hold PRQR?
Other major institutional holders of PRQR include Privium Fund Management B.V., Ikarian Capital, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.